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The placenta is the extraembryonic organ that supports the fetus during intrauterine 21 
life. Although placental dysfunction results in major disorders of pregnancy with 22 
immediate and lifelong consequences for both mother and child, our knowledge of the 23 
human placenta is limited due to lack of functional experimental models1. Upon 24 
implantation, the trophectoderm of the blastocyst rapidly proliferates and generates the 25 
trophoblast, the unique cell type of the placenta. In vivo, the proliferative villous 26 
cytotrophoblast cells (VCT) differentiate into two main sub-populations: 27 
syncytiotrophoblast (SCT), the multinucleated epithelium of the villi responsible for 28 
nutrient exchange and hormone production, and extravillous trophoblast (EVT) that 29 
anchor the placenta to the maternal decidua and transform the maternal spiral 30 
arteries2. Here, we describe the generation of long-term, genetically-stable organoid 31 
cultures of trophoblast cells that can differentiate to SCT and EVT. We used HLA-32 
typing to confirm the organoids are fetally-derived, and verified their identity against 33 
four trophoblast-specific criteria3. The cultures organise into villous-like structures, and 34 
we detected secretion of placental-specific peptides and hormones, including hCG, 35 
GDF15, PSGs and PAPPA, by mass spectrometry. The organoids also differentiate to 36 
HLA-G+ EVT that vigorously invade in 3D. Analysis of the methylome reveals the 37 
organoids closely resemble normal first-trimester placentas. This organoid model will 38 
be transformative for studying human placental development and for investigating 39 
trophoblast interactions with the local and systemic maternal environment. 40 
 To devise an organoid culture system suitable for trophoblast, we focussed on 41 
maternal and placental products that might signal to the stem/progenitor cells that reside in 42 
areas of Ki67+ VCT proliferation and/or at the base of the cytotrophoblast cell columns 43 
(CCC) that give rise to EVT (Fig.1a,b)4–9. We investigated signalling pathways between 6-8 44 
weeks g.a when proliferation is high: WNT through β-catenin; TGFβ through SMAD2/3; 45 
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MAPK through Erk1/2 and STAT3. Our findings led to empirical trials of 46 
agonists/antagonists, along with other agents, which resulted in a basal Trophoblast Organoid 47 
Medium (TOM) composed of EGF, FGF2, CHIR99021 (a WNT activator), A83-01 (a 48 
TGFβ/SMAD inhibitor) and Rspondin-1 (Extended Data Fig. 1a-d). To prepare isolates of 49 
trophoblast cells, first trimester placentas (6-9 weeks g.a) were enzymatically digested to 50 
enrich for cell clusters containing EPCAM+ cells; EPCAM marks proliferative trophoblast 51 
(Fig. 1c)10. Cell clusters were seeded into Matrigel drops and grown in TOM. Although some 52 
growth was seen, we also tested factors used in other organoid systems and/or present in the 53 
first trimester microenvironment (Extended Data Fig. 2a, Supplementary Table 1a). HGF, 54 
PGE2 and Y-27632 (a ROCK inhibitor) increase cell viability and growth and, when they are 55 
combined with TOM, there is rapid growth of cells within a week (Fig. 1d, Supplementary 56 
Table 1b). After the first passage, organoid structures appear and homogeneous trophoblast 57 
organoids are established within 2 passages (10-14 days) with an efficiency of 91% (20/22 58 
patient samples). To confirm their fetal origin, we used microsatellite analysis and HLA 59 
typing (Extended Data Table 1). Derivation of the organoids in TOM in the absence of each 60 
factor reveals that EGF is the most important, with effects also seen with Y-27632, A83-01 61 
and CHIR99021. We have now derived trophoblast organoids that are genetically stable after 62 
many passages (Extended Data Fig. 2b,c); three randomly selected cultures are still growing 63 
after a year (Supplementary Table 1c), are healthy and show active mitochondrial function 64 
(Extended Data Fig. 2d). Maternal epithelial cells are always detectable by flow cytometry in 65 
placental cell isolates. Nicotinamide enriches for cystic structures resembling glandular 66 
organoids at early stages of derivation (Extended Data Fig. 2a), and microsatellite analysis 67 
and HLA typing confirmed their maternal origin (Extended Data Table 2). By selecting the 68 
appropriate media, we can derive both decidual glandular and trophoblast organoid cultures 69 
from the same pregnancy (Extended Data Fig. 2e)11. This highlights the importance of 70 
verifying the maternal or fetal origin of any cultures derived from decidual or placental cell 71 
isolates.  72 
The trophoblast identity of the organoids was verified on the basis of our previously 73 
defined criteria: they express GATA3, KRT7, EGFR, TFAP2A and TFAP2C; they lack 74 
expression of HLA class I molecules; they express ELF5 and its promoter is hypomethylated; 75 
and they express microRNAs from the C19MC miRNA complex at similar or higher levels to 76 
choriocarcinoma lines, JEG-3 and JAR (Fig. 2a-d; Extended Data Fig. 3a-f; Source data Files 77 
1-2)3. To assess how well the trophoblast organoids recapitulate their tissue of origin in an 78 
unbiased approach, we performed a microarray analysis of established organoids and 79 
compared them to first-trimester placental villi (also containing stromal, Hofbauer and 80 
endothelial cells) and cultured villous stromal cells. To check for maternal cell 81 
contamination, decidual glandular organoids were included. The results were analysed by 82 
PCA and hierarchical clustering (Fig 2e,f, Extended Data Fig. 4a,b).  PC1 shows trophoblast 83 
organoids cluster closely to the placenta with enrichment for trophoblast-specific genes, 84 
CGB3, GATA3 and PSG6, compared to the stromal cells and glandular organoids. PC2 85 
highlights epithelial genes (CLDN3, TACSTD2 and KRT23), specific for trophoblast 86 
compared to other placental cells (Extended Data Fig. 4b). IHC confirms that KRT23 is a 87 
novel trophoblast-specific keratin placental villi and in trophoblast organoids (Extended Data 88 
Fig. 4c). Comparison of differentially expressed genes (fold change≥2, adjusted P 89 
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value≤0.05) between placental villi, trophoblast organoids and stromal cells highlights other 90 
genes of interest, such as PGF, CCNE1, ERBB3 and FOLR1; translation of CCNE1 in 91 
trophoblast was validated by IHC (Extended Data Fig. 4e). Imprinted genes, PEG3 and 92 
PEG10 are also highly expressed in the trophoblast organoids (Extended Data Fig. 4d). 93 
Amongst transcription factors, beside known genes, GATA3 and TFAP2C, new genes 94 
emerged such as ELF3 (Extended Data Fig. 5a,b). Genome-wide methylation analysis 95 
revealed a high degree of correlation between trophoblast organoids and first-trimester 96 
placental villi across different genomic elements compared to blood and brain (Fig. 2g).  The 97 
hypomethylation of ELF5 promoter was also confirmed (Extended Data Fig. 5c,d).  Analysis 98 
of the promoter regions of genes with similar methylation patterns to Elf5 in mouse TS cells 99 
shows that ELF5, EZR, TINAGL1 and LASP1 are similarly hypomethylated in placental villi 100 
and trophoblast organoids (Extended Data Fig. 5e,f)12. Gene ontology analysis of DEGs, 101 
represented by Chord plot, shows terms describing metabolic processes and cell-cell 102 
organization converging on epithelial, developmental and hormonal pathways, FZD5 (WNT 103 
signalling), INSIG1 (insulin signalling), DHCR7 (cholesterol synthesis) and OCLN 104 
(polarity)(Extended Data Fig. 5g). 105 
Trophoblast organoids grow as complex structures closely recapitulating the structure 106 
of placental villi in vivo where VCT stain for EPCAM and CDH1 (Fig. 3a,b). The basement 107 
membrane is on the outside in contact with Matrigel with syncytial masses lining the central 108 
cavity (Extended Data Fig. 6a). Similar to in vivo, VCT cells are Ki67+ and TP63+ (Fig. 3b, 109 
Extended Data Fig. 6b,c). Following incubation with EdU, ~30-40% of cells are proliferating 110 
when the organoids are small (100-200μm diameter), with a notable decrease as they enlarge 111 
and differentiate (Extended Data Fig. 6d). Expression of SCT markers (CD71, CD46) is 112 
found inside the organoids (Extended Data Fig. 6e). These characteristic features of SCT 113 
were confirmed by electron microscopy (EM): multinucleated with abundant secretory 114 
organelles and surface microvilli (Fig. 3c). Lacunae present within the syncytial areas 115 
resemble those found in vivo (Extended Data Fig. 6f,g). GCM1 drives fusion of VCT into 116 
SCT by upregulating ERVW-1 (SYNCYTIN-1)13,14. Using qRT-PCR, we detect high levels of 117 
expression of GCM1 and ERVW-1, comparable to those in the placenta (Fig. 3d; Source Data 118 
File 2). Thus, trophoblast organoids closely mimic the villous placenta both structurally and 119 
phenotypically. SCT secretes proteins and hormones into the maternal systemic circulation, 120 
inducing maternal adaptations to pregnancy. We explored the secretory activity of trophoblast 121 
organoids through an unbiased peptidomic analysis of the organoid medium and LC MS/MS 122 
technology (Fig. 4a). Among the most abundant peptides are placental-specific PSGs and 123 
INSL4, whose functions are unknown (Extended Data Table 3, Supplementary Table 2a-h). 124 
Aldose reductase, which converts glucose to sorbitol is also detected. High concentrations of 125 
sorbital are present in first trimester placentas15. Hence, the organoids also mimic the villous 126 
placenta metabolically as well as endocrinologically. Peptides that induce physiological and 127 
metabolic adaptations during pregnancy, including hCG, KISS1 and CSH1 are all abundant 128 
as well as GDF15, implicated in hyperemesis gravidarum16. GDF15 and hCG are detected by 129 
ELISA, showing that full-length and appropriately folded hormones are secreted by 130 
trophoblast organoids (Fig. 4b,c; Source Data Files 3-4). Indeed, the ‘pregnant’ secretome of 131 
the organoids is evident using an “over-the-counter” pregnancy test kit (Fig. 4d).  132 
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Human trophoblast also differentiates to EVT, a process crucial for proper 133 
placentation. EVT express HLA-G and invade decidual tissue to transform the spiral 134 
arteries17. In TOM our trophoblast organoids show only sporadic HLA-G+ cells (Extended 135 
Data Fig. 7a). Recently, long-term, 2D monolayer cultures of human trophoblast cells derived 136 
from first-trimester placentas that can differentiate into SCT and EVT were described18. By 137 
adapting their EVT differentiation protocol and culturing both our trophoblast organoids and 138 
primary villous explants in their EVT medium (EVTM), HLA-G+ cells appear that migrate 139 
out of the organoids, digest the Matrigel to form tracks, and eventually adhere to the plastic 140 
(Fig. 5a-e, Extended Data Fig. 7b, Supplementary Videos 1-6). In vivo EVT are generated at 141 
the base of CCCs where cells express ITGA210. We used flow cytometry to confirm that, 142 
after exposure of organoids to EVTM, HLA-G+ EVT appear and ITGA2+ cells disappear 143 
(Fig. 5f). 144 
In summary, we describe the generation of human trophoblast organoids that grow as 145 
complex 3D structures with fusion of VCT to hCG-secreting SCT, anatomically and 146 
functionally closely resembling the villous placenta in vivo. In addition, we show 147 
differentiation to HLA-G+ EVT that vigorously invade and digest the Matrigel in 3D. 148 
Following the submission of our paper, there is a report describing the generation of 149 
trophoblast organoids from pooled patient samples; however these cannot be cultured long-150 
term and have not been fully characterised19. Our findings complement those of Okae et al. 151 
and mean that there are now two culture systems (2D and 3D) for human trophoblast18. Our 152 
3D model has the advantage of organising into complex structures generating both SCT and 153 
EVT. The retention of the normal villous structure will allow analysis of morphogenetic 154 
events. We anticipate that these two different models will provide valuable tools across a 155 
range of disciplines. They can be used to study maternal-fetal transmission of xenobiotics, 156 
drugs and pathogens, and the proteins and hormones derived from the SCT20. Analysis of 157 
CCC formation and EVT differentiation in vitro will allow investigation of the decidual 158 
microenvironment on trophoblast function, such as the effect of glandular histotrophic 159 
nutrition and the influence of the distinctive uterine natural killer (NK) cells21,22. Major 160 
unexplained disorders of pregnancy such as pre-eclampsia, stillbirth and fetal growth 161 
restriction have their origins in aberrant placental development in the first trimester23. 162 
Trophoblast organoids can be used to study maternal-fetal interactions following 163 
implantation, and the maternal physiological, metabolic and hormonal changes occurring 164 
during pregnancy.   165 
 166 
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METHODS 246 
Patient samples. All tissue samples used for this study were obtained with written informed consent 247 
from all participants in accordance with the guidelines in The Declaration of Helsinki 2000. Elective 248 
terminations of normal pregnancies were performed at Addenbrooke’s Hospital (6-9 weeks gestation) 249 
under ethical approval from the Cambridge Local Research Ethics Committee (04/Q0108/23). Human 250 
peripheral blood was collected from a healthy donor in a BD vacutainer following informed consent 251 
and in accordance with the ethical approval of the Human Biology Research Ethics Committee, 252 
University of Cambridge (HBREC.2016.03). 253 
Derivation of trophoblast organoids from human placental tissue. To obtain trophoblast-enriched 254 
cell suspensions, villi from first trimester placental tissue were sequentially digested with 0.2% 255 
trypsin-250 (Pan Biotech P10-025100P)/0.02% EDTA (Sigma #E9884)/PBS then collagenase V at 256 
1.0mg/ml (Sigma #C9263) in Hams F12/10% FBS. Both digests were pooled, washed in Advanced 257 
DMEM/F12 medium (Gibco #12634-010) and re-suspended in ~10x volume growth-factor-reduced 258 
Matrigel (Corning #356231) on ice. 25µL drops were plated per well into a 48-well culture plate 259 
(Costar #3548), set at 37°C for 15min and overlaid with 250µL Trophoblast Organoid Medium 260 
(TOM, Supplementary Table 1b). Cultures were maintained in 5% CO2 in a humidified incubator at 261 
37°C. Medium was replaced every 2-3d. Small organoid clusters became visible by ~7d and were 262 
passaged when at least 50% had reached a diameter of 200-300µm (usually between 7-10d). 263 
Mechanical disruption was achieved with Eppendorf Explorer Plus automatic pipettes on a mix cycle 264 
of 99 rounds (x4-5), maximum speed.  Organoids from the same sample were initiated and maintained 265 
in the absence of each individual component to test its importance. Frozen stocks of organoids were 266 
made in 70% TOM, 20% FBS and 10% DMSO freeze medium and stored in liquid nitrogen. A step-267 
by-step protocol of the derivation and maintenance of human trophoblast organoid cultures can be 268 
found at Nature Protocol Exchange24. 269 
Generation of EVT from trophoblast organoids. Trophoblast organoids were passaged and plated 270 
into 35mm dishes or ibidi μ-dishes (Thermo Scientific #81156). Differentiation was achieved through 271 
a modification of the protocol used by Okae et al18. After passaging, organoids were maintained in 272 
TOM for 3-4d and switched to EVT medium (EVTM: advanced DMEM/F12, 0.1mM 2-273 
mercaptoethanol (Gibco #31350), 0.5% Penicillin-streptomycin, 0.3% BSA (Sigma #A8412), 1% 274 
ITS-X supplement (Gibco #51500-056), 100ng/mL NRG1 (Cell Signaling #5218SC), 7.5μM A83-01 275 
(Tocris Biotechne #2939), 4% Knockout serum replacement (ThermoFisher #10828010). When 276 
organoids showed outgrowth of cells (typically 7-10d), the medium was changed to EVTM without 277 
NRG1 for a further 7-10d. For comparison, fresh placental villi were embedded into 300uL Matrigel 278 
in ibidi μ-dishes and grown under the same conditions. 279 
Isolation of placental stromal cells. Placental villous stromal cells were isolated by digesting the 280 
tissue remaining after the initial trypsin/collagenase digests in 10-15mL collagenase V in Hams 281 
F12/10% FBS with gentle shaking at 37°C for 5-10min. The cell suspension was filtered through 282 
gauze, washed and pelleted. Cells were resuspended in Advanced DMEM/F12/10% FBS with 283 
additional L-Glutamine, non-essential amino acids (Gibco #11140-035) and primocin (Invivogen 284 
#ant-pm-1) and seeded into tissue culture flasks. They were cultured to 80-90% confluency and 285 
passaged once before use. 286 
Peripheral blood monocytes (PBMC) isolation. PBMC were isolated from blood by Pancoll-based 287 
(Pan-Biotech #P04-60500) density gradient separation. PBMC viability was >95% by Trypan Blue 288 
exclusion. PBMC were resuspended in QIAzol lysis reagent (Qiagen #79306) for total RNA extraction 289 
following the supplier’s protocol. 290 
Cell lines. Human choriocarcinoma cell lines, JEG-3 and JAR, were obtained from the American 291 
Type Culture Collection (ATCC) and cultured as previously described3. 292 
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Immunohistochemistry (IHC). Organoids were formalin-fixed and embedded as previously 293 
described11. IHC on sections of organoids and first-trimester placentas was performed using 294 
A.Menarini heat-induced epitope retrieval buffers and Vectastain avidin-biotin-HRP reagents as 295 
previously described11. Primary antibodies (Supplementary Table 3) were replaced with equivalent 296 
concentrations of isotype-matched mouse or rabbit IgG for controls. Images were captured with a 297 
Zeiss Axiovert Z1 microscope and Axiovision imaging software SE64 V4.8. 298 
Immunofluorescence (IF) and confocal microscopy. Trophoblast organoids were grown in 4-5 299 
20μL Matrigel drops in 35mm ibidi μ-dishes and EdU and/or antibody labelling was performed as 300 
previously described11. EdU incubation was for 1h at 37°C in TOM containing 10μM EdU. For 301 
primary antibodies and secondary antibodies used see Supplementary Table 1d. Imaging was with the 302 
ZEISS 700 Confocal microscope and ZEN Microscope Software.  303 
Mitotracker staining. Mitochondrial function was evaluated by Mitotracker Red-CMXRos 304 
(Thermofisher #M7512). Organoids were released from Matrigel with Cell Recovery Solution 305 
(Corning #354253) and incubated in 500nM of Mitotracker Red in TOM in suspension at 37°C for 30 306 
mins. The organoids were washed in basal medium, resuspended and plated into a thin layer of 307 
Matrigel in ibidi μ-dishes for imaging on a ZEISS 700 Confocal microscope with ZEN Microscope 308 
Software. 309 
Time-lapse microscopy. Trophoblast organoids or placental villous explants embedded in 300uL of 310 
Matrigel in 35mm ibidi μ-dishes were imaged in phase-contrast and across several z-stacks on a Zeiss 311 
Axiovert Z1 microscope with the multidimensional imaging function of the Axio Observer software 312 
Axiovision image software V4.8.  The images were compiled into a single movie by using the 313 
extended focus wavelet function.  314 
ELISA. Conditioned media were harvested from organoid cultures and centrifuged to remove debris 315 
and stored at -80°C until use. Human Chorionic Gonadotropin β (hCG-β) ELISA (Abcam #ab108638) 316 
was performed on 50μL supernate with 100μL sample buffer in duplicate alongside hCG-β standards 317 
following the manufacturer’s instructions.  Concentration of hCG-β in the supernates was calculated 318 
from the line formula of the standard plots in Microsoft Office Excel.  Supernatants were also tested 319 
with Clear&Simple Digital Pregnancy Test following manufacturer’s instructions. Image reproduced 320 
with the permission of SPD Swiss Precision Diagnostics GmbH (SPD). GDF-15 was measured by in-321 
house electrochemiluminescence immunoassay on the MesoScale Discovery assay platform (MSD) 322 
using BioTechne DuoSet antibodies and standard (BioTechne #DY957). For further details see 323 
Supplementary Methods.  324 
Flow cytometry. Organoids were removed from Matrigel with Cell Recovery Solution and 325 
dissociated with 0.2% trypsin 250 (Pan Biotech P10-025100P)/0.02% EDTA (Sigma #E9884) in PBS 326 
at 37°C for 5 min.  Cells were washed in medium containing FBS and passed through a 40μm cell 327 
strainer (Falcon #2340). Cells were blocked with human IgG (Sigma #I4506) in DPBS (ThermoFisher 328 
Scientific #14190136)/1%FBS prior to labelling with W6/32-Alexa-488 anti-HLA-A,B,C antibody, 329 
HLA-G-PE, ITGA2-PE or isotype-matched controls (Supplementary Table 1d).  LIVE/DEAD™ 330 
Fixable Far Red Dead Cell Stain (Life Technologies #L10119) was used for live/dead discrimination. 331 
Data were acquired using Cytek Development DxP8 (488/637/561). Data were analysed in FlowJo 332 
(Tree Star) and all compensation was applied digitally after acquisition.  333 
In Situ Hybridization (ISH) Assays. ISH for LGR5 was performed on 4μm paraffin sections with 334 
RNAscope 2.0 High definition assay (Advanced Cell Diagnostics) following the manufacturer’s 335 
instructions.  Briefly, tissue sections were baked at 60°C for 1h, dewaxed with xylene, cleared in 336 
100% ethanol and air-dried prior to the standard protocol: 10min in Pretreat buffer 1, 15min in 337 
Pretreat buffer 2 and 30min at 37°C in Pretreat buffer 3 followed by incubation with LGR5 probe 338 
(#311021), positive control probe UBC (#310041) or negative control probe dapB (#310043) for 2h at 339 
40°C. Signal was visualized with the amplification kit and DAB for 10min. Sections were dehydrated, 340 
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mounted in DPX (Sigma #44581) and imaged on a Zeiss Axiovert Z1 microscope with Axiovision 341 
imaging software SE64 V4.8. 342 
Electronic microscopy (EM). Trophoblast organoids were directly fixed in 35mm dishes with 0.5% 343 
glutaraldehyde/0.2 M sodium cacodylate buffer (pH 7.2) for 30min and reduced with osmium 344 
tetroxide as previously described11. Ultrathin sections were examined in an FEI Tecnai G2 TEM at 345 
80Kv. Images were acquired with MegaView III CCD and Soft Imaging Systems program. Samples 346 
from human placentas were fixed by immersion in 3% glutaraldehyde-0.3% hydrogen peroxide in 347 
0.1mol/L 1,4-piperazine diethane sulfonic acid (PIPES) buffer (pH 7). After 2h at RT, tissue was 348 
washed for 30min in 0.1 mol/L PIPES buffer. Secondary fixation was by immersion in 1% osmium 349 
tetroxide in PIPES buffer for 1h at RT. After washing, specimens were dehydrated in graded ethanol 350 
and embedded in Araldite epoxy resin. Ultrathin sections (50nm) were cut on a Reichert-Jung Ultracut 351 
S (Reichert-Jung). Sections were counterstained with uranyl acetate, followed by lead citrate, before 352 
viewing in a Philips CM100 electron microscope (Philips Electronics). 353 
DNA extraction and quantification. QIAamp DNA blood Mini kit (Qiagen #51104) was used to 354 
extract genomic DNA from patients’ blood for Short tandem repeat analysis, HLA tissue typing and 355 
Bisulphite sequencing. DNA was extracted from trophoblast organoids, decidual and placental tissues 356 
by digestion with ATL buffer (Qiagen #19076) and Proteinase K (Sigma #P4850), followed by 357 
purification steps with RNase A (Sigma #R6513) and Protein Precipitation Solution (Qiagen 358 
#158910). DNA was precipitated with isopropanol and washed with 70% ethanol. DNA quality and 359 
concentration were determined in a Nanodrop ND-1000 Spectrophotometer. 360 
Comparative Genomic Hybridization (CGH) analysis. DNA from two independently derived 361 
trophoblast organoid samples at early and late passages was analysed with Agilent Sureprint G3 362 
unrestricted CGH ISCA 8x60K array (Agilent #G4450A). DNA samples from late passage organoids 363 
were compared to early passage organoids (hybridization control). DNA was diluted to 50ng/uL and 364 
labelled using the Agilent kit following manufacturer’s instructions.  Data analysis for segmentation 365 
and copy number calls was performed at a genome-wide resolution of 500kb by the default analysis 366 
method – CGH v2 from the Agilent CytoGenomics software Edition 2.5.8.11 (Build 37). 367 
Short tandem repeat analysis and HLA typing. Microsatellite analysis was performed with the 368 
GenePrint® PowerPlex™16 System (Promega) involving fluorescent labelled multiplexed PCR 369 
amplification of 15 short tandem repeat (STR) loci and Amelogenin sex determining fragments. PCR 370 
fragment size resolution was achieved with capillary electrophoresis on a 3730XL DNA Analyzer 371 
(Applied Biosystems) before analysis of the raw data and STR allele calling with GeneMapper 372 
Versions 4 and 5 (Life technologies) fragment analysis sizing and genotyping software. All typing 373 
was performed blind. The Promega PowerPlex 16 kit was designed for Forensic testing and has a 374 
sensitivity capable of detecting down to 5% contamination. It is used by for monitoring of post-375 
haematopoietic stem cell transplant chimerism25,26. The DNA for HLA genotyping was processed via 376 
the workflows of the EFI accredited Clinical Histocompatibility Laboratory. Low resolution typing of 377 
the HLA-A, -B and -C genes was achieved with LABType kits (One Lambda) which rely on reaction 378 
patterns observed when sequence specific DNA probes immobilised on fluorescent X-MAP 379 
polystyrene beads (Luminex) hybridise to biotin labelled multiplexed gene specific PCR amplicons. 380 
The hybrids were detected with a Liquichip 200 fluorimeter (QIAgen) and HLA allele assignment 381 
was from HLA Fusion software (One Lambda). Ultra High resolution typing of HLA-A, -B, -C, - 382 
DRB1, - DQB1 and -DPB1 was achieved with an ‘in house’ Third Generation Sequencing pipeline 383 
utilising Pacific Biosciences’ Single Molecule Real-Time DNA sequencing technology as previously 384 
described27.  385 
Bisulphite sequencing. Approximately 300ng of DNA was used for bisulphite conversion performed 386 
with the EpiTect Bisulfite Kit (Qiagen #59110), according to the manufacturer’s protocol. The ELF5 387 
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promoter region was amplified as described previously28. PCR products were cloned and sequenced, 388 
confirming representation of distinct alleles. 389 
Global DNA methylation analysis. Genomic DNA bisulfite (BS) was performed with the CEGX  390 
TrueMethyl kit (Cambridge  Epigenetix /NuGEN) and used for microarray-based DNA methylation  391 
analysis, performed at GenomeScan (GenomeScan B.V., Leiden, The  Netherlands), on the  392 
HumanMethylation850 BeadChip (Illumina) and were scanned on the Illumina iScan system. The 393 
resulting iDAT files were imported and analysed by ChAMP (v2.9.10)29,30. Samples were processed 394 
filtering for a probe detection p-value <= 0.01, probes with a bead count <3 in at  least 5% of samples,  395 
no CpG and known SNPs at probe starts, probes aligning to multiple locations, and QC using the on  396 
array control probes31. Of the total probes on the array 755577 passed the filtering and QC steps. The 397 
BMIQ method was used to normalise the two probe types present on the array. Beta methylation 398 
values from the EPIC array range from 0 (unmethylated) to 1 (methylated) and are equivalent of 399 
percentage methylation32. Genomic annotations were imported from FDb.InfiniumMethylation.hg19 400 
and  IlluminaHumanMethylationEPICmanifest33. Genomic features in Fig. 2g comprise the following 401 
numbers of assayed CpGs: CpG Islands, 48799, 48799, 13576; Promoters, 151270, 151270, 88621; 402 
Gene Bodies, 280,284,280,284,117,138; LINE1, 48799, 48799, 13576. Boxplots comprise min: 1.5 x 403 
inter-quartile, lower: 1st quartile, middle: median, upper: 3rd quartile, max: 1.5 x inter-quartile range 404 
(Extended Data Figures 2G and 5e). Density/violin plots are scaled to area. LINE1 elements were 405 
downloaded as tables from UCSC Genome browser for hg1930. Maternal blood samples (normal) are 406 
taken from E-GEOD-66210. 407 
RNA extraction, quantification and quality control. Total RNA was isolated using the miRNeasy 408 
isolation kit (Qiagen #217004) with on-column DNAse digestion (Qiagen #79254). Quantitation of 409 
RNA was performed with the Quant-iT™ RiboGreen™ RNA Assay Kit (Thermo Fisher Scientific 410 
#R11490) by measuring the intensity of fluorescence at 528nm with a Synergy HT Multi-Mode 411 
Microplate Reader (BioTek Instruments) according to manufacturer's instructions. RNA quality was 412 
assessed on the Agilent 2100 bioanalyzer (Thermo Fisher Scientific). RNA Integrity Number (RIN) of 413 
each tested sample was greater or equal to 8.  414 
Reverse transcription and Real-time quantitative RT-PCR (qRT-PCR). The expression of ELF5, 415 
ERVW-1 and GCM1 was analysed with Taqman Gene expression assays (Applied Biosystems). 416 
500ng-1μg of total RNA was reverse transcribed with Superscript VILO Reverse Transcriptase 417 
(Thermo Fisher Scientific #11754050) in the presence of random hexamers and RNAse inhibitor 418 
following supplier’s instructions. qRT-PCR was performed on 7900HT Fast Real-Time PCR system 419 
(Applied Biosystems) as previously described11. Relative expression levels were normalised to the 420 
geometric mean of three housekeeping genes HPRT1, TOP1 and TBP and the 2-∆Ct method. The 421 
expression of C19MC miRNAs hsa-miR-517-5p, hsa-miR-517(a, b)-3p, hsa-miR-526b-3p, hsa-miR-422 
525-3p and reference gene RNU48 were analysed by TaqMan miRNA assays (Applied Biosystems). 423 
10ng of total RNA were reverse transcribed using miRNA specific stem-loop RT primers and 424 
TaqMan microRNA reverse transcription kit (Applied Biosystems #4366596) according to the 425 
supplier’s instructions. QRT-PCR assays were run with qPCRBIO Probe Mix Lo-ROX (PCR 426 
Biosystems) containing specific probes on an Eppendorf Mastercycler® RealPlex 2 instrument. Ct 427 
data were normalised to the RNU48 internal control by the 2-∆Ct method. All qPCR reactions included 428 
no-template controls and minus RT controls (–RT). For further details and for Taqman Assay IDs for 429 
each gene see Supplementary Methods. 430 
Microarray expression profiling and data analysis. The microarray experiment was performed at 431 
Cambridge Genomic Services at University of Cambridge with a species specific Gene 2.1 ST Array 432 
Plate (Affymetrix) according to manufacturer’s instructions. Briefly, 100ng of total RNA was 433 
amplified for each sample with inline PolyA spike-in control and the WT PLUS amplification kit 434 
(Affymetrix). By using the in line hybridization controls, we successfully amplified samples with the 435 
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GeneChip WT terminal labelling kit (Affymetrix). Plate arrays were processed on the GeneTitan 436 
instrument (Affymetrix) with the GeneTitan Hybridization, Wash and Stain kit (Affymetrix). Samples 437 
were hybridized to the array, washed, stained and scanned. CEL files generated were loaded in R 438 
using the oligo package from Bioconductor. The raw data were then processed after quality controls 439 
using the Robust Multichip Analysis method. The limma package (3.34.8) was used to make the 440 
comparisons, and results were corrected for multiple testing using False Discovery Rate. Microarray 441 
probes without gene identifier (ensembl gene id) were filtered out. Initial QC included PCA and MDS 442 
plots. Finally the quality of the data was assessed, and the correlation of the samples in the groups 443 
compared. Heatmaps were generated with the R package 'pheatmap' (1.0.8), which uses the Euclidean 444 
method.  For the gene heatmaps, the input is the normalized intensity matrix. GO terms enrichment 445 
was obtained with R package 'clusterProfiler' (3.6.0) with function `enrichGO`, and chord plots were 446 
generated with the R package 'GOplot' (1.0.2). 447 
LC-MS analysis of trophoblast organoid supernatants. Trophoblast organoids (day 10 after 448 
passaging) were grown in trophoblast organoid medium and supernatants collected after overnight 449 
incubation. The supernatants (500µL) and an aliquot of growth media were acidified with 50µL of 1% 450 
formic acid in water (v/v) and loaded directly onto an Oasis Prime µ-elution 96 well SPE plate 451 
(Waters #186008052) and extracted as described previously34. The eluant was evaporated under 452 
oxygen free nitrogen at 40ºC and reconstituted into 75µL of 50mM ammonium bicarbonate in water 453 
with 10mM dithiothreitol. Protein digests were prepared and analysed using an Ultimate 3000 nano 454 
LC system coupled to a Q Exactive Plus Orbitrap mass spectrometer (ThermoScientific) as described 455 
previously35. The nano LC/MS files obtained from the six different extracts were combined and 456 
searched using Peaks 8.5 software (BSI) against the human Swissprot database (Downloaded on 26-457 
Oct-2017). A tryptic digest setting was used and precursor and product ion tolerances were set at 10 458 
ppm and 0.05 Da respectively. The search parameters included a fixed modification of a 459 
carboxyamidomethylation on cysteine residues and variable modifications such as methionine 460 
oxidation, N-terminal pyro-glutamate, N-terminal acetylation and C-terminal amidation. A false 461 
discovery rate (FDR) value of 1% was applied at the peptide and a minimum of 1 unique peptide also 462 
was required. For further details see Supplementary Methods. 463 
Statistics and Reproducibility. All experiments reported in this study have been reproduced with 464 
similar results derived from independent samples (tissues and organoids) from multiple patients. The 465 
number of times the experiments were repeated with independently-derived trophoblast organoid 466 
cultures are reported in figure legends as (n=) and summarized in Supplementary Table 1c. Given the 467 
descriptive nature of the work and biological variation between human samples, the experimental data 468 
points for each patient sample are shown separately unless stated otherwise. Trophoblast organoid 469 
culture protocols were independently replicated by four scientists. Statistical analyses used to analyse 470 
microarray, methylation and LC-MS data are reported in Methods above. 471 
Data availability. Microarray data for Figure 2, Extended Data Figures 4 and 5 have been deposited 472 
in the ArrayExpress database at EMBL-EBI under accession number E-MTAB-6683 473 
(https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-6683). Illumina EPIC Methylation array 474 
data for Figure 2 and Extended Data Figure 5 have been deposited in the ArrayExpress database at 475 
EMBL-EBI under accession number E-MTAB-7204.  476 
(https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-7204). Code used to analyse microarray 477 
data and EPIC  array  samples  is  available  at  https://github.com/CTR-BFX/2018-Turco-Moffett. 478 
The mass spectrometry proteomics data for Extended Data Table 3 and Supplementary Table 2 have 479 
been deposited to the ProteomeXchange Consortium via the PRIDE36 partner repository 480 
(www.ebi.ac.uk/pride/archive/) with the dataset identifier PXD009118 and 10.6019/PXD009118. All 481 
source data for graphs are in Supplementary Table 3. All other data supporting the findings of this 482 
study are available from the corresponding authors upon reasonable request. 483 
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FIGURE LEGENDS 523 
Figure 1. Establishment of long-term organoid cultures of trophoblast from human placentas. a, 524 
A placental villus at the maternal-fetal interface in the first trimester of pregnancy showing the 525 
different trophoblast subsets: SCT, VCT, CCC and EVT. Sources of the intrinsic and extrinsic signals 526 
that could signal to proliferative Ki67+ trophoblast cells (dark blue) are shown. b, IHC for Ki67 in 527 
early first trimester placenta (6-8 weeks g.a) compared to late first trimester (10-12 weeks g.a.). The 528 
proportion of proliferative cells is greatly reduced towards the end of first trimester and the cells are 529 
localized mostly in the CCC. Representative images from n=6 for each tissue type. Scale bars, 100μm. 530 
c, IHC for EPCAM on first trimester placenta (6-8 weeks g.a.) and cell clusters from placental digests. 531 
Experiment independently repeated twice with similar results. Arrowheads show VCT and CCC are 532 
EPCAM+ and these cells are present in the cell clumps from the placental digests. Scale bars, 50μm 533 
(placenta) and 200μm (placental digest). d, Time course for derivation of trophoblast organoids from 534 
one placental isolate. Bright field images of Matrigel drops after seeding placental digests starting 535 
from passage 0 day 0, until generation of homogenous trophoblast organoids (passage 2, day 7). For 536 
passages 0 and 1, timepoints at day 0 and 7 are shown. Passage 2, day 7 is shown together with the 537 
zoom of the boxed area in the lower panel. Experiment independently repeated for all organoid 538 
cultures with similar results. Scale bars, 500μm (Matrigel droplet images) and 200μm (zoom in on 539 
trophoblast organoids). Gestational age, g.a.; SCT, syncytiotrophoblast; VCT, villous cytotrophoblast; 540 
CCC, cytotrophoblast cell column; EVT, extravillous trophoblast; DG, decidual gland; SA, spiral 541 
artery; pl, placental; dec, decidual.  542 
Figure 2. Trophoblast organoids retain characteristic features of first trimester trophoblast in 543 
vivo, and similar transcriptome and global methylation profiles. a, IHC for TFAP2C shows 544 
uniform expression (representative images from n=20). Scale bars, 50μm. b, FACS analysis of three 545 
trophoblast organoids (TOrg10, 12, 14) and JEG (positive control) with mAb W6/32 .Gating strategy 546 
see Extended Data Fig. 3c. Experiment independently repeated 3 times. c, Bisulfite sequencing of the 547 
ELF5 promoter region of trophoblast organoids (TOrg 6) and matched maternal leukocytes (positive 548 
control). Relative % of methylated cytosine residues (filled circles) are indicated. d, qPCR analysis 549 
for miR517-3p from C19MC cluster on trophoblast organoids (n=6), JEG-3 and JAR choriocarcinoma 550 
(Chc.) lines (positive controls) and peripheral blood monocytes (PBMC). Graph shows relative 551 
expression levels to housekeeping gene RNU48. Source Data File 1. e, PCA of placental villi (n=8); 552 
trophoblast organoids derived from different placentas, TOrg_1 (passage p4), TOrg_2 (p7), TOrg_3 553 
(p6), TOrg_4 (p4) and TOrg_5 (p6) (n=5); placental stromal cells (n=5); and decidual organoids 554 
(n=3). Analysis based on 12673 probes. Organoids cluster more closely with placental villi on PC1 555 
axis. f, Clustered heatmap of differentially expressed genes in first trimester placental villi 556 
(n=8)(blue), trophoblast organoids (n=5)(pink) and cultured placental villous stromal cells 557 
(n=5)(green). g, Distribution of methyl-cytosine across genomic features is similar between 558 
trophoblast organoids (n=4) and placental samples (n=4). In contrast, the brain (n=1) and maternal 559 
blood (n=5) samples show distinct patterns, especially across CpG islands, gene bodies and LINE1 560 
elements. Pearson’s correlation coefficient (R) indicated for each comparison against trophoblast 561 
organoid samples (all p values <2.2e-16). Density/violin plots are scaled to area. 562 
Figure 3. Trophoblast organoids form complex structures resembling placental villi with 563 
formation of syncytiotrophoblast (SCT). a, Confocal microscopy images of trophoblast organoid 564 
stained for F-actin, EPCAM, DAPI merged with phase image (representative image from n=5). The 565 
EPCAM+ cells are surrounding the organoid. Scale bar, 100μm. b, IHC for CDH1 and Ki67 of first 566 
trimester placenta  and trophoblast organoids (representative images from n=6 for Ki67 and n=20 for 567 
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trophoblast organoids). VCT stains positively for CDH1. Ki67 is present in the inner VCT layer in 568 
villi and the outer layer in organoids. Scale bar, 50μm. Higher power in insets scale bar, 20μm. c, 569 
Electron micrograph images of first trimester SCT compared to the centre of a trophoblast organoid. 570 
Surface microvilli (arrowheads) and multinucleated areas can be seen (arrows). Scale bars, 5μm 571 
(placenta), 1μm (trophoblast organoids, microvilli) and 2.5μm (trophoblast organoids, nuclei). 572 
Representative images from n=2. d, qPCR analysis of genes ERVW-1 and GCM1 in trophoblast 573 
organoids (n=5) compared to whole placental villi (n=8) and stromal cells isolated from the placenta 574 
(n=5). Graphs show expression levels relative to geometric mean of three housekeeping genes TBP, 575 
TOP1 and HPRT1. The mean ERVW-1 and GCM1 expression are shown for each sample group. 576 
Source Data File 2. 577 
 578 
Figure 4. Secretome of trophoblast organoids contains placental hormones and proteins. a, 579 
Experimental work-flow for Liquid chromatography-mass spectrometry (LC-MS) analysis of the 580 
secretome of trophoblast organoids. Supernatants from six trophoblast organoid cultures derived 581 
independently from six different placental samples were analysed: TOrg_2 (p23), TOrg_3 (p20), 582 
TOrg_5 (p6), TOrg_10 (p12), TOrg_12 (p4) and TOrg_14 (p5). b, ELISA for GDF15 secreted by 583 
trophoblast organoids (n=6). Shown is amount of GDF15 (ng/mL) produced by trophoblast organoids 584 
(between day 7-10 after passaging) in 48h. Source Data File 3. c, ELISA for HCGβ secreted by 585 
trophoblast organoids (n=5). Shown is amount of HCGβ (ng/mL) produced by trophoblast organoids 586 
(between day 7-10 after passaging) in 48h. Source Data File 4. d, Over-the-counter pregnancy stick 587 
denoting “Pregnant” after being placed into dish containing cultures of trophoblast organoids. Image 588 
reproduced with the permission of SPD Swiss Precision Diagnostics GmbH (SPD). Experiment 589 
independently repeated twice. 590 
 591 
Figure 5. Generation of migratory and invasive HLA-G+ extravillous trophoblast (EVT) cells 592 
from trophoblast organoids. a, Phase-contrast images taken across several z-stacks combined into a 593 
single image by the extended focus module from Zeiss Axiovision of a trophoblast organoid and b, a 594 
placental villous explant plated into Matrigel after 7-10 days in EVT differentiation medium (EVTM). 595 
Regions of interest in samples are boxed in white and corresponding higher power snapshots are 596 
shown with relative time-lapse intervals in yellow (h:min). Migratory cells are labelled with yellow 597 
arrowhead. In EVTM, cells from both the organoids and primary tissue show random migration. See 598 
also control image for organoid in TOM (Extended Data Fig. 7b and time-lapse videos 599 
(Supplementary Videos 1-6). Scale bars, large images in a and b 200μm; images shown from insets, 600 
50μm. c, Phase contrast images of trophoblast organoids plated in Matrigel drop and exposed to either 601 
TOM or EVTM.  Cells stream out of organoids, digesting the Matrigel and eventually adhering to the 602 
plastic only when cultured in EVTM. Scale bars, 200μm. d, Live cells growing out from trophoblast 603 
organoids in EVTM stained with HLA-G monoclonal antibody, G233. Scale bar, 50μm. e, Flow 604 
cytometry of trophoblast organoids cultured in TOM or EVTM and double-stained with monoclonal 605 
antibodies W6/32 (binds all HLA class I molecules) and MEMG9 (specific for HLA-G).  In TOM 606 
virtually all cells lack HLA class I expression but become HLA-G+ after culturing in EVTM. f, 607 
Histogram showing organoids cultured in TOM or EVTM stained for ITGA2, that marks cells at the 608 
base of the cytotrophoblast cell columns.  Before exposure to EVTM, 23% cells are ITGA2+ but very 609 
few are present after differentiation to HLA-G+ EVT. All experiments (a-f) have been repeated 610 
independently at least 3 times. 611 
 612 
EXTENDED DATA LEGENDS 613 
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Extended Data Figure 1. Staining for signalling pathways in first trimester placenta and 614 
decidua. a, IHC of first trimester placenta (6-8 weeks g.a.) for effectors of major signalling pathways 615 
(i) WNT signalling, non-phosphorylated (p)-β-catenin (S33/S37/T41), (ii) TGFβ signalling through p-616 
SMAD 2 (S465/467)/Smad3 (S423/425), (iii) MAPK signalling through p-ERK 1/2 (T202/Y204) and 617 
(iv) p-STAT3 (Y705) signalling. Scale bars, 50μm. Representative images from n=8, for each 618 
antibody. BMP signalling through SMAD1/5/8 was not possible to assess by IHC. VCT and CCC 619 
displayed membrane-localised staining of non-p β-catenin, whereas p-Erk1/2 was mostly cytoplasmic 620 
in both cell types. Cytoplasmic and nuclear signals for p-Erk1/2 were detected in EVT. P-SMAD 2/3 621 
staining also showed stronger nuclear signals in EVT, suggesting a role for TGFβ signalling in 622 
differentiation in accordance with previous report9. Phosphorylated nuclear STAT3 was detected only 623 
in EVT, again indicating involvement in their differentiation. SCT was negative for all these signals. 624 
b, Summary of findings from a. Trophoblast cells from different regions of the placenta are 625 
represented as a circle with nucleus (small inner circle). Black indicates strong staining, grey indicates 626 
faint staining and white not detected. Thicker circles indicate staining localized to cell membrane. c, 627 
In situ hybridization for LGR5 on first trimester placental villi. LGR5 transcripts are detected in VCT. 628 
Stroma is negative. Positive control probe is for UBIQUITIN (UBC). Negative control probe is for the 629 
bacterial gene dapB. Nuclei are counterstained in Haematoxylin. Images are at x10 magnification. 630 
Representative images from n=2. d, IHC for Rspondin-1 on early first trimester (6-8 weeks g.a.) and 631 
late first trimester (10-12 weeks g.a.) decidual samples. Representative images from n=2 for each 632 
tissue type. Images are at x20 magnification. SCT, syncytiotrophoblast; VCT, villous cytotrophoblast; 633 
CCC, cytotrophoblast cell columns; EVT, extravillous trophoblast; UG, uterine glands. 634 
Extended Data Figure 2. Culture components tested for the establishment of long-term organoid 635 
cultures of trophoblast from human placentas. a, Growth factors (HGF, PGE2, Y-27632, 636 
Nicotinamide) were added as supplements to basal trophoblast organoid medium (TOM) that contains 637 
EGF, CHIR99021, Rspondin-1, A83-01, FGF2 (Supplementary Table 1a,b). Bright field images of 638 
placental digests at passage 1, day 7. The cystic structures that appear with the addition of 639 
Nicotinamide (red asterisks) are contaminating maternal glandular organoids. Representative images 640 
from n=2. Conditions containing factors that did not show growth are not included. Scale bars in 641 
upper and lower rows, 500μm. b, Trophoblast organoid cultures at passage 2 and at passage 10 with 642 
continuous culture. Representative images from n=3. Scale bars, 500μm. c, Analysis of genetic 643 
stability of cultures (n=2) with comparative genomics hybridization (CGH) array. Shown is a 644 
representative whole-genome array CGH plot generated with Agilent Cytogenomics software. 645 
Genomic DNA from late passage (p8) trophoblast organoids is compared to genomic DNA from early 646 
passage (p2). Each spot is a single probe. Plotted are the log ratios of the average signal intensity of 647 
each probe on the Y-axis along its position on the chromosomes (1-22, X and Y) on the x-axis. A log 648 
signal ratio of 0 represents equivalent copy number the samples. No significant DNA copy number 649 
abnormalities were identified. d, Live imaging of trophoblast organoid cultures (n=2) passaged >6 650 
months and then frozen/thawed and exposed to Mitotracker Red. Functional mitochondria are visible 651 
showing that the cells are healthy (white arrowheads). Scale bars, whole organoid 50μm; Individual 652 
cells 10μm. e, Organoids derived from the same placental cell isolate using either trophoblast 653 
organoid medium (TOM) or Decidual organoid medium (ExM) demonstrating that matched placental 654 
(fetal) and decidual (maternal) organoids can be derived from the one sample. Representative bright 655 
field images from n=3. Scale bars, 500μm. 656 
 657 
Extended Data Figure 3. Trophoblast organoids retain characteristic features of first trimester 658 
trophoblast in vivo. a, Representative images of positive staining for GATA3, KRT7, EGFR and 659 
DAPI on trophoblast organoids by confocal microscopy (representative image from n=3). EGFR 660 
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stains both VCT and the surface of SCT as in vivo7. The basement membrane is around the outside of 661 
the organoids with formation of syncytial masses in the centre. Scale bar, 50μm. b, IHC for 662 
transcription factor TFAP2A shows uniform expression on trophoblast organoids (representative 663 
image from n=20). Scale bars, 50μm. c, Gating strategy used for flow cytometric analysis of single, 664 
live cells from trophoblast organoids. d, Quantitative RT-PCR (qPCR) analysis of ELF5 in 665 
trophoblast organoids (n=5) compared to whole placental villi (n=8) and stromal cells isolated from 666 
the placenta (n=5). Graph shows expression levels relative to the geometric mean of three 667 
housekeeping genes TBP, TOP1 and HPRT1. The mean ELF5 expression is shown for each sample 668 
group. Source Data File 2. e, Bisulfite sequencing of the ELF5 promoter region (-379bp to -28bp 669 
upstream of the transcription start site) of trophoblast organoids from two different placentas (TOrg 3, 670 
6) and matched maternal blood leukocytes (positive control). The relative % of methylated cytosine 671 
residues (filled circles)  are indicated. f, qPCR analysis for miR525-3p, miR526-3p and miR517-5p 672 
from C19MC miRNA cluster on trophoblast organoids (n=6), JEG-3 and JAR (positive controls) and 673 
peripheral blood monocytes (PBMC, low expression/negative control). Graph shows relative 674 
expression levels of each organoid culture to housekeeping gene RNU48. Source Data File 1. 675 
 676 
Extended Data Figure 4. Hierarchical clustering of microarray data comparing placental villi, 677 
trophoblast organoids and placental stromal cells. a, Unsupervised hierarchical clustering analysis 678 
of global gene expression profiles by microarray of first trimester placental villi (Pl)(n=8), trophoblast 679 
organoids (TOrg)(n=5), placental stromal cells (Str)(n=5) and decidual organoids (DOrg)(n=3). 680 
Analysis was based on 12673 probes. The expression profiles of trophoblast organoids cluster with 681 
first trimester placental samples whilst decidual organoids and placental stromal cells cluster in a 682 
separate tree. b, Top 20 genes contributing to PC1 and PC2 in the PCA plot from Fig. 2e. The top 683 
genes contributing to PC1 are all trophoblast-specific genes such as CGB3, GATA3 and PSG6 684 
indicating that these genes separate the trophoblast organoid and placental villous samples from the 685 
two potentially-contaminating, non-trophoblast samples (decidual organoids and placental stroma). 686 
The top genes contributing to PC2 are epithelial genes such as CLDN3, TACSTD2 and KRT23. The 687 
organoids only contain trophoblast, but cells of the villous core (stromal, Hofbauer and endothelial 688 
cells) are also present in the placental samples. c, IHC of placental villi and trophoblast organoids 689 
stained for KRT23 showing expression in all trophoblast cells in vivo and in vitro. Experiment 690 
repeated independently 3 times. Scale bar, 50μm. Higher power in insets scale bar, 20μm. d, 691 
Clustered heatmap of differentially expressed genes between trophoblast organoids, placental villi and 692 
placental stroma with an absolute log2 fold change of 2 (adjusted p.value < 0.05). e, IHC of placental 693 
villi and trophoblast organoids stained for CCNE1 showing expression in trophoblast cells in vivo and 694 
in vitro. Scale bar, 50μm. Higher power in insets scale bar, 20μm. Experiment repeated independently 695 
3 times. 696 
 697 
Extended Data Figure 5.  Transcription factor expression profiles of trophoblast organoids and 698 
placental villi. a, Heatmap highlighting transcription factors from the differentially expressed genes 699 
between placental villi, trophoblast organoids and placental stromal cells. b, Heatmap of genes from 700 
the ELF family of transcription factors and syncytial genes, GCM1 and ERVW-1. ELF3 and ELF5 701 
both show moderate expression levels across the organoids and placental samples, and very low/no 702 
expression in the stromal samples. ELF4 and ELF1 are similar in all samples. There is very high 703 
expression of  ELF1 in placentas and organoids. Similarly, both ERVW-1 and especially GCM1 are 704 
expressed at higher levels in placentas and organoids in agreement with qPCR data (Fig. 3d). c, 705 
Genomic mapping of the methylation array probes to the ELF5 gene. The height of the bars indicates 706 
methylation level from 0, unmethylated to 1.0, fully methylated. d, Methylation of the ELF5 promoter 707 
shows hypomethylation in the organoid and placenta samples. e, Distribution of methyl-cytosine 708 
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across the promoters of the 10 murine trophoblast gatekeeper genes12. The organoids (Org) and 709 
placenta (PL) samples show very similar methylation patterns across all 10 gene promoters that are 710 
distinct from the control/brain (CL) and maternal-blood (MB) in the majority of the genes. Boxplots 711 
comprise min: 1.5 x inter-quartile, lower: 1st quartile, middle: median, upper: 3rd quartile, max: 1.5 x 712 
inter-quartile range. Significant correlations (<0.01) are indicated (*).  f, Table showing Pearson’s 713 
correlation coefficient (R), number of CpG/probes compared and p-values for e. g, Chord plot 714 
representing terms from the gene ontology analysis of upregulated genes in trophoblast organoids.  715 
 716 
Extended Data Figure 6. Structure and proliferation in trophoblast organoids. a, A schematic 717 
diagram of a normal placental villus in vivo compared to a trophoblast organoid.  The basement 718 
membrane (BM) beneath the VCT is contiguous with the stromal villous core in vivo and with the 719 
Matrigel in vitro.  The SCT contacts maternal blood in the intervillous space in vivo. SCT forms in the 720 
centre of the organoids. b, IHC for TP63 in first trimester placenta and trophoblast organoids 721 
(representative images from n=14). TP63 is expressed in VCT. Scale bar, 50μm. Higher power insets 722 
scale bar, 20μm. c, Representative images of TP63, Ki67 and DAPI staining on trophoblast organoids 723 
by confocal microscopy (n=3). Cells on the outside of the organoids are TP63+ and Ki67+. Scale 724 
bars, 20μm.  d, Confocal microscopy images of trophoblast organoid stained for EdU, EPCAM and 725 
DAPI showing fewer proliferating cells (white arrowheads) as the organoids enlarge. Scale bar, 50μm. 726 
Representative images from n=3. e, IHC for markers of SCT, CD46 and CD71, in first trimester 727 
placenta and trophoblast organoids (representative images from n=20). CD46 and CD71 stain the 728 
syncytial brush border. Scale bar, 50μm. Higher power insets scale bar, 20μm. f, Carnegie stage 5b 729 
embryo (~9 days post-fertilization)from Carnegie Collection at the early lacunar stage (number 8171). 730 
Courtesy of Prof. Enders and the Centre for Trophoblast Research 731 
(https://www.trophoblast.cam.ac.uk/Resources/enders). Arrows point to examples of cavities that 732 
appear in the primitive syncytium due to fluid accumulation before the coelomic cavity and the 733 
embryo have fully developed.g, Similar cavities in placental tissue samples from first trimester (6-9 734 
weeks g.a) and in syncytium in centre of trophoblast organoids. Boxed areas are shown at higher 735 
magnification (bottom). Scale bars, 200μm (top); 50μm (bottom). Similar morphology seen in at least 736 
5 early placental villi and in all organoids. ICM, inner cell mass. Pr.Syn. primitive syncytium; VCT, 737 
villous cytotrophoblast; SCT, syncytiotrophoblast; Str, stromal core.  738 
 739 
Extended Data Figure 7.  Trophoblast organoids grown in TOM and EVTM. a, Confocal image 740 
of organoid stained for F-actin, DAPI and HLA-G.  A few isolated cells stain for HLA-G (white 741 
arrowheads) at the periphery of the organoid. Scale bar, 50 μm. Representative image from n=3. b, 742 
Phase contrast images from time-lapse videos of 16h of trophoblast organoids grown in TOM when 743 
EVT differentiation does not occur (top).  No invasive cells are visible.  Shown for comparison is an 744 
organoid (middle) and a placental villous explant exposed to EVTM (bottom).  Black arrows indicate 745 
cells migrating and arrowheads show visible tracks made as the cells invade through the Matrigel. For 746 
time-lapse videos of these cultures see Supplementary Videos 1, 4 and 5. Scale bars, 200μm. 747 
 748 
Extended Data Table 1. Microsatellite analysis and HLA typing of organoids from placental 749 
digests in TOM show that they are of fetal origin a, PowerPlex16 Short Tandem Repeat (STR) 750 
genotyping of DNA from matched maternal-fetal samples (maternal blood, decidua and placenta) to 751 
identify origin of organoids. Shown in top row are the 15 STR loci analysed. Numbered STR alleles 752 
observed for each DNA at a particular locus are listed within the relevant column. As expected in 753 
most cases a maximum of two alleles were seen. In cases where there was evidence of an additional 754 
allele from a fetal derived STR haplotype the allele number appears in brackets. This is consistent 755 
with the decidua containing fetal extravillous trophoblast. The results at informative loci where fetus 756 
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and trophoblast organoids match are underlined.   b, HLA genotyping with Third Generation SMRT 757 
sequencing of DNA from matched maternal blood and trophoblast organoid to confirm STR analysis. 758 
HLA-A, -B, -C, -DRB1, -DQB1 and -DPB1 loci were investigated. The two HLA alleles at each locus 759 
defined at high resolution are shown for each sample. For each locus, the fetal trophoblast will share 760 
one allele with the mother but the other allele will be derived from the father and is likely to be 761 
different.  Not all loci are informative as some paternal and non-inherited maternal alleles are the 762 
same. 763 
Extended Data Table 2. Microsatellite analysis and HLA typing of organoids from placental 764 
digests derived in ExM show that they are of maternal origin a, PowerPlex16 STR genotyping of 765 
DNA from matched maternal-fetal samples (decidua, maternal blood, placenta) to identify origin of 766 
organoids. Shown in the top row are the 15 STR loci analysed. Numbered STR alleles observed for 767 
each DNA at a particular locus are listed within the relevant column. As expected in most cases a 768 
maximum of two alleles were seen but where there was lesser evidence of an additional allele from a 769 
fetal derived STR haplotype the allele number appears in brackets. The results at informative loci 770 
where maternal blood, decidua and organoids match are underlined. b, HLA genotyping with 771 
LABType Reverse SSO of DNA from 4 pregnancies with matched decidua, blood, placenta and 772 
organoids. Each pair of HLA alleles defined, at low resolution, for each sample at a particular locus 773 
are listed within the relevant column. The maternal origin of the organoids is clear from HLA-A, -B 774 
and -C alleles in 3 of the 4 pregnancies. The data was inconclusive for pregnancy 2 but all 4 organoids 775 
are clearly maternal in origin when using both methods (see above). 776 
Extended Data Table 3. Liquid chromatography-mass spectrometry (LC-MS) analysis of the 777 
secretome of trophoblast organoids. Supernatants from independently-derived trophoblast organoid 778 
cultures from six different placental samples were analysed: TOrg_2 (p23), TOrg_3 (p20), TOrg_5 779 
(p6), TOrg_10 (p12), TOrg_12 (p4) and TOrg_14 (p5). Table shows the glycoproteins, classical 780 
peptides/protein hormones, placental specific peptides and proteins enriched in placental tissue 781 
identified in the secretome data by LC-MS. The -10lgP value is the statistical significance assigned to 782 
a peptide/protein match by the PEAKS software37. Coverage% refers to the proportion of the primary 783 
amino acid sequence of each protein that is identified in the experiment. #Peptides refers to the 784 
number of peptide matches assigned to a protein, whilst #Unique refers to the number of peptides that 785 
are assigned solely to that protein group. #Spec refers to the number of peptide MS/MS spectra 786 
matched against a particular protein. The columns also indicate whether these are unique products 787 
produced by the placenta and/or whether they are products produced by other tissues but highly 788 
enriched in the placenta (among the top 10 organs producing that protein based on RNA expression 789 
levels). Tissue location data was compared to data from the Human Protein Atlas, 790 
https://www.proteinatlas.org/. All protein identification data are in Supplementary Table 2. 791 
 792 
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